MHC superfamily structure and the immune system

Current Opinion in Structural Biology

Volumn 9, Issue 6, 1999, Pages 745-753

  Maenaka, Katsumi ^a   Jones, E Yvonne ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

ANIMALIA; MURINAE;

EID: 0032761773     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(99)00039-1     Document Type: Review

References (75)

1. Elliott T. How does TAP associate with MHC class I molecules? Immunol Today. 18:1997;375-379.
2. b upon peptide binding. Biochemistry. 37:1998;3001-3012.
3. Bouvier M., Wiley D.C. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/β2m heterodimer. Nat Struct Biol. 5:1998;377-384. The first information on the biophysical characteristics of an MHC class I molecule in the absence of bound peptide.
4. Ghosh P., Amaya M., Mellins E., Wiley D.C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:1995;457-462.
5. Jasanoff A., Song S., Dinner A.R., Wagner G., Wiley D.C. One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules. Immunity. 10:1999;761-768. The results of NMR analysis reported in this paper allowed the authors to begin to develop a model of the Ii-MHC class II complex during class II assembly.
6. Jasanoff A., Wagner G., Wiley D.C. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J. 17:1998;6812-6818. The structure of the stable trimeric domain of Ii (invariant chain protein), as revealed by NMR spectroscopy. This skillful structure determination provides significant insight into the mode of function of Ii.
7. ••], will now guide functional studies.
8. ••].
9. Fan Q.R., Wiley D.C. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med. 190:1999;113-123. The structure of a C allele human MHC class I molecule is added to the database. A full sample of these human allele structures is essential to our understanding of peptide-binding motifs.
10. •]).
11. •].
12. Menssen R., Orth P., Ziegler A., Saenger W. Decamer-like conformation of a nona-peptide bound to HLA-B* due to non-standard positioning of the C terminus. J Mol Biol 1999. 285:3501;645-653.
13. b class I molecule devoid of the central anchor ("C") pocket. J Immunol. 160:1998;2815-2823.
14. Bouvier M., Guo H.C., Smith K.J., Wiley D.C. Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group. Proteins. 33:1998;97-106.
15. Smith K.J., Pyrdol J., Gauthier L., Wiley D.C., Wucherpfennig K.W. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med. 188:1998;1511-1520. This report extends the structural database of MHC class II alleles to include a complex of particular importance in autoimmune disease.
16. •], further extends the range of the MHC class II structural database.
17. •].
18. b/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity. 10:1999;63-74. A comparison of MHC class I-glycopeptide structures implicates flexibility as a potentially important determinant of T-cell receptor cross-reactivity.
19. •], provides our first views of MHC class I-glycopeptide complexes.
20. Zhao R., Loftus D.J., Appella E., Collins E.J. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med. 189:1999;359-370. This paper compares human and murine MHC class I structures recognised by the same T-cell receptor. As such, it moves forward our ideas on the molecular basis of cross-reactivity.
21. d peptide complexes. Immunity. 8:1998;553-562. This paper illuminates more subtle mechanisms for allowing cross-reactivity.
22. Ghendler Y., Teng M.K., Liu J.H., Witte T., Liu J., Kim K.S., Kern P., Chang H.C., Wang J.H., Reinherz E.L. Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands. Proc Natl Acad Sci USA. 95:1998;10061-10066. A comparison of structures that re-emphasises findings, for example, as reported in [23], that subtle structural differences in the MHC-peptide complex can result in very different T-cell receptor signalling functions.
23. Reid S.W., McAdam S., Smith K.J., Klenerman P., O'Callaghan C.A., Harlos K., Jakobsen B.K., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med. 184:1996;2279-2286.
24. Garcia K.C., Degano M., Stanfield R.L., Brunmark A., Jackson M.R., Peterson P.A., Teyton L., Wilson I.A. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
25. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., Wiley D.C. Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
26. Teng M.K., Smolyar A., Tse A.G., Liu J.H., Liu J., Hussey R.E., Nathenson S.G., Chang H.C., Reinherz E.L., Wang J.H. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes. Curr Biol. 8:1998;409-412.
27. Garcia K.C., Teyton L., Wilson I.A. Structural basis of T cell. Annu Rev Immunol. 17:1999;369-397.
28. Ding Y.H., Smith K.J., Garboczi D.N., Utz U., Biddison W.E., Wiley D.C. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity. 8:1998;403-411. A lovely insight into the similarities and differences in how two T-cell receptors recognise the same MHC class I-peptide ligand.
29. Garcia K.C., Degano M., Pease L.R., Huang M., Peterson P.A., Teyton L., Wilson I.A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1998;1166-1172. The second MHC-TCR complex to be refined particularly serves to emphasise the unusually low degree of surface complementarity in this interaction. This is in spite of the large induced fit of the TCR complementarity determining region loops on binding to MHC class I molecules that the authors found on comparing unliganded and liganded structures.
30. ••].
31. Ding Y.H., Baker B.M., Garboczi D.N., Biddison W.E., Wiley D.C. Four A6 TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity. 11:1999;45-56. This report beautifully highlights the subtlety of the structural differences that are sufficient to change grossly the functional outcome of T-cell receptor binding.
32. Kersh G.J., Kersh E.N., Fremont D.H., Allen P.M. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity. 9:1998;817-826. Surface plasmon resonance studies point to the importance of the off-rate as the major determinant of the outcome in T-cell receptor signalling.
33. •], begins to reveal a model for the nature of the extracellular trigger in T-cell signalling.
34. •].
35. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., Jakobsen B.K. Crystal structure of the complex between human CD8α (α) and HLA-A2. Nature. 387:1997;630-634.
36. b. Immunity. 9:1998;519-530. This paper on the murine system provides impact confirmation of the generality of the conclusions derived from the human system [35].
37. Fan Q.R., Mosyak L., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature. 389:1997;96-100.
38. •].
39. •], reports the crystal structure of a second member of the KIR family. Unexpectedly, the interdomain orientation of the KIR molecules is shown to be variable.
40. Boyington J.C., Riaz A.N., Patamawenu A., Coligan J.E., Brooks A.G., Sun P.D. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity. 10:1999;75-82. The first structural information on the C-lectin-type family of natural killer cell receptors, the cognate receptors for the nonclassical MHC class Ib molecule HLA-E.
41. Wyer J.R., Willcox B.E., Gao G.F., Gerth U.C., Davis S.J., Bell J.I., van der Merwe P.A., Jakobsen B.K. T cell receptor and coreceptor CD8αα bind peptide-MHC independently and with distinct kinetics. Immunity. 10:1999;219-225. Surface plasmon resonance analysis shows the much weaker binding affinity of MHC-CD8 than MHC-TCR. The presence of CD8 does not increase the affinity of the TCR-MHC class I molecule interaction.
42. •], these data underpin our understanding of the structure/function relationship of this family of receptors.
43. •], killer cell immunoglobulin receptors (KIRs) are shown to have similar binding characteristics to those seen in other cell adhesion receptor interactions.
44. Wilson I.A., Bjorkman P.J. Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs. Curr Opin Immunol. 10:1998;67-73.
45. Zeng Z., Castano A.R., Segelke B.W., Stura E.A., Peterson P.A., Wilson I.A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science. 277:1997;339-345.
46. Burmeister W.P., Huber A.H., Bjorkman P.J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372:1994;379-383.
47. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., McMichael A.J., Bell J.I., Jones E.Y. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell. 1:1998;531-541. The first structure determination of a human nonclassical MHC Ib molecule coincides with the elucidation of its function. The mode of peptide binding retains many of the standard features observed in MHC class Ia complexes, but additional, novel hydrophobic pockets equip HLA-E to bind the specific MHC class I leader sequence.
48. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 93:1998;111-123. As described in [49], insight into structure and function is contemporaneous. For HFE, this approach has illuminated our understanding of an impact genetic disease.
49. Lebron J.A., Bjorkman P.J. The transferrin receptor binding site on HFE, the class I MHC related protein mutated in hereditary hemochromatosis. J Mol Biol. 289:1999;1109-1118.
50. ••], represents the most distant structural outposts of the MHC superfamily.
51. Li P., Willie S.T., Bauer S., Morris D.L., Spies T., Strong R.K. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity. 10:1999;577-584. In MIC-A, the standard helical turn that links the α1α2 peptide-binding domain with α3 in all other MHC class I-type molecules is replaced with four residues in an extended chain conformation, giving an apparently flexible link. This change allows the adoption of a completely nonstandard MHC class I quaternary structure in the crystal.
52. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
53. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen HLA-A2. Nature. 329:1987;506-512.
54. Saper M.A., Bjorkman P.J., Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol. 219:1991;277-319.
55. Madden D.R., Garboczi D.N., Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 75:1993;693-708.
56. Collins E.J., Garboczi D.N., Wiley D.C. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature. 371:1994;626-629.
57. Garrett T.P., Saper M.A., Bjorkman P.J., Strominger J.L., Wiley D.C. Specificity pockets for the side chains of peptide antigens in HLA Aw68. Nature. 342:1989;692-696.
58. Silver M.L., Guo H.C., Strominger J.L., Wiley D.C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature. 360:1992;367-369.
59. Guo H.C., Jardetzky T.S., Garrett T.P., Lane W.S., Strominger J.L., Wiley D.C. Different length peptides bind to HLA Aw68 similarly at their ends but bulge out in the middle. Nature. 360:1992;364-366.
60. Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.C. The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. Proc Natl Acad Sci USA. 92:1995;1218-1221.
61. Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1992;1035-1048.
62. Smith K.J., Reid S.W., Stuart D.I., McMichael A.J., Jones E.Y., Bell J.I. An altered position of the α 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity. 4:1996;203-213.
63. b. Science. 257:1992;919-927.
64. Zhang W., Young A.C., Imarai M., Nathenson S.G., Sacchettini J.C. Crystal structure of the major histocompatibility complex class I H2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci USA. 89:1992;8403-8407.
65. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA. 92:1995;2479-2483.
66. Young A.C., Zhang W., Sacchettini J.C., Nathenson S.G. The three-dimensional structure of H2Db at 2.4 Å resolution: implications for antigen-determinant selection. Cell. 76:1994;39-50.
67. d-peptide complex explains the unique interaction of Ld with β-2 microglobulin and peptide. Proc Natl Acad Sci USA. 94:1997;6880-6885.
68. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:1994;215-221.
69. Murthy V.L., Stern L.J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure. 5:1997;1385-1396.
70. Kim J., Urban R.G., Strominger J.L., Wiley D.C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science. 266:1994;1870-1874.
71. Jardetzky T.S., Brown J.H., Gorga J.C., Stern L.J., Urban R.G., Chi Y.I., Stauffacher C., Strominger J.L., Wiley D.C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 368:1994;711-718.
72. Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C. X-ray crystal structure of HLA-DR4 (DRA* DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997. 7:0101;473-481.
73. Fremont D.H., Hendrickson W.A., Marrack P., Kappler J. Structures of an MHC class II molecule with covalently bound single peptides. Science. 272:1996;1001-1004.
74. Wang C.R., Castano A.R., Peterson P.A., Slaughter C., Lindahl K.F., Deisenhofer J. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell. 82:1995;655-664.
75. Vaughn D.E., Bjorkman P.J. Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure. 6:1998;63-73.